Breaking News

Sirona Biochem Names CEO

October 12, 2012

Belenkie brings extensive business and healthcare experience

Neil Belenkie has been appointed chief executive officer of Sirona Biochem Corp. Dr. Howard Verrico will remain chairman of the board.
 
“Neil Belenkie brings to Sirona Biochem the experience, determination and network we need to accelerate growth,” said Dr. Dr. Verrico, Sirona Biochem’s founder and chairman of the board. “Sirona Biochem’s programs have matured from scientific concepts to compounds showing commercial potential.  It’s the right time to welcome Neil Belenkie’s leadership to Sirona Biochem to propel these programs forward.”
  
Neil Belenkie, a winner of Business in Vancouver Magazine’s Top 40 Under 40, brings his significant healthcare experience to Sirona Biochem. Mr. Belenkie’s career in life sciences includes leadership roles in sales, market research, marketing, and medical education. He is the founder of strategic management consulting company GrowthPoint Group, which provides business solutions for long-term growth. His life sciences background includes leadership roles at Ortho Biotech and Hoffman LaRoche.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks